We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Cetuximab in Patients With Unresectable or Metastatic Hepatocellular Carcinoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00142428
Recruitment Status : Completed
First Posted : September 2, 2005
Last Update Posted : March 18, 2014
Dana-Farber Cancer Institute
Beth Israel Deaconess Medical Center
Brigham and Women's Hospital
Bristol-Myers Squibb
Information provided by (Responsible Party):
Andrew X. Zhu, MD, Massachusetts General Hospital

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : October 2005
  Study Completion Date : October 2008